CEO, Korro Bi
Senior Director – Technical Solutions, Asymchem
Professor, Chemical Engineering & Institute for Medical Engineering & Science, MIT
Senior Director, Corporate Development & Marketing, Anima Biotech
SVP, Global Biologics, US Pharmacopeia
Head of Advanced Drug Delivery, AstraZeneca
CEO, Orna Therapeutics
CMO, Ascidian Therapeutics
Proposal Manager, AGC Biologics
Commercial Manager, Particle Works
VP Delivery Platform, Beam Therapeutics
CEO, Tiger Gene Venture Capital
Managing Director, Life Science Investments, Wharton Alumni Angels
Senior Science Correspondent, Endpoints News
Business Development Director, Micropore Technologies
Head of Strategic Partnership & Innovation, mRNA, Sanofi
Professor of Pharmaceutics & Drug Delivery, Butler University
CEO, Switch Therapeutics
CMO, Tessera Therapeutics
VP for Clinical Development, BioNTech
CEO, AUM Biosciences
Professor, Developmental & Cell Biology & Chancellors Fellow, UC Irvine
SVP, Infectious Disease and Vaccines, Laronde
VP, Clinical Development, Gritstone bio
CSTO, Avidity Biosciences
Managing Director, Certest Biotec
Head of Oligonucleotide Process Chemistry, Biogen
Co-Founder & Scientific Director, Elsie Biotechnologies
Director, Discovery Research, Dicerna Pharmaceuticals
CMO, QurAlis
Product Manager, Certest
AVP, Genetic Medicine, Eli Lilly
Global Head of RNA, Gene Therapy & Delivery, Janssen
CTO, Eleven Therapeutics
CCO, Synthgene
Founder & Head of R&D, MiNA Therapeutics
CEO , TAmiRNA
VP, CBO, Gritstone
VP & Head of Translational & Clinical Pharmacology, Biorchestra
CBO, Intellia Therapeutics
Partner, UCB Ventures
SVP, Alnylam Pharmaceuticals
CSO, Cartesian Therapeutics
CEO, Omega Therapeutics
Senior Applications Scientist, Unchained Labs
CMC Lead, CEPI
CEO, Elixirgen
Director of Delivery Sciences, Laronde
Partner, MRL Ventures Fund
SVP RNA Biochemistry & Manufacturing, BioNTech SE
CSO, Nanovation Therapeutics
Director, Innovation, Specialty Chemicals and Engineered Materials, Entegris
CEO, CSO, 4basebio
Chairman & CEO, Arthex Biotech
Principal Investigator, University of Oxford
VP, Head of Bioanalytical, DMPK, PenGen
VP of Venture Science, Eli Lilly
VP, WuXi AppTec
CEO, CAMP4 Therapeutics
Senior Director & Head of Molecular Pharmacology, Arrakis
COO & CBO, Stoke Therapeutics
Head of Chemistry, ReVir Therapeutics
CEO, Momentum Biotechnologies
COO, Laronde
Co-CEO & Founder, Sixfold bioscience
Head of RNA Therapeutics, Abzu
CEO, Senda Bioscience
Senior Business Editor, Genetic Engineering & Biotechnology News
Co-Founder & VP, Discovery Research, Entrada Therapeutics
Senior Manager, Business Development and Strategy, METis Therapeutics
Head of Drug Discovery, Remix Therapeutics
Associate VP of Genetic Medicine External Partnerships & Academic Collaborations, Eli Lilly
EVP of Portfolio Strategy and Product Development, Capstan Therapeutics
Co-Founder & CEO, Ethris
Senior Director, Head of RNA & Protein Modulation, Takeda
Associate Director, mRNA Center of Excellence, Sanofi
CEO, Impilo Therapeutics
Sr Director, Innovation and Strategy, Aldevron
Head of Bio Innovation Hub Transformative Research Unit, Novo Nordisk
CEO President, Ascidian Therapeutics
EVP of Research, Ionis
CTO, Nucleic Acids Exothera
Business Development Analyst, Ziphius Vaccines
Director of Discovery, 4basebio
Senior Director, Head of Technology Development, Sirnaomics
CEO, Autonomous Therapeutics
CEO, Alltrna
CEO, Hc Bioscience
CEO, ReviR Therapeutics
VP, Nucleic acid technology, ReciBioPharm
